Together, these findings establish SOD enzymes as key redox regulators in cancer biology: their overexpression supports tumor adaptation under oxidative stress, while their inhibition reveals critical vulnerabilities—particularly in the case of SOD1—that may be therapeutically exploitable. The gene discussed is SOD1; the disease is cancer.